Reversibility Of Alcohol Dilated Cardiomyopathy

Home » Alcohol Ejection Fraction » Reversibility Of Alcohol Dilated Cardiomyopathy

Maybe your like

Search by title, keywords, or author Ampliar Vol. 71. Num. 8. Pages 603-605 (August 2018) Previous article Next article Editorial Reversibility of Alcohol Dilated Cardiomyopathy

Reversibilidad de la miocardiopatía dilatada alcohólica

Joaquim Fernández Solà Unidad de Alcohología, Servicio de Medicina Interna, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain Affiliations See less Related content Related content Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy Rev Esp Cardiol. 2018;71:612-910.1016/j.rec.2017.11.032 Almudena Amor-Salamanca, Gonzalo Guzzo-Merello, Esther González-López, Fernando Domínguez, Alejandra Restrepo-Córdoba, Marta Cobo-Marcos, Manuel Gómez-Bueno, Javier Segovia-Cubero, Luis Alonso-Pulpón, Pablo García-Pavía https://doi.org/10.1016/j.rec.2018.01.016 View PDF Lea este artículo en español Share

Options

Options Images 2 Tools Statistics Related content
  • Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy
Other articles of interest
  • Diagnosis of Long QT Syndrome: Time to Stand Up!
  • Circulating Amyloid-Beta (1-40) Predicts Clinical Outcomes in Patients With Heart Failure
  • Pulmonary Hypertension–Back to the Future
  • Medically–managed Patients With NonST-segment Elevation Acute Coronary Syndromes: An Ill-defined Entity
  • The Role and Impact of Gut Microbiota in Cardiovascular Disease
Figure 1 Figure 1 Figure 2 Figure 2 Tools
  • Export citation to RIS format
  • Export citation to BibTeX format
  • Export citation to text format
  • Add to Mendeley
plumx Statistics Read 38174 Times the article has been read 3628 Total PDF 34546 Total HTML
Year/month Html Pdf Total
2026 March 178 31 209
2026 February 466 32 498
2026 January 606 50 656
2025 December 580 102 682
2025 November 418 81 499
2025 October 322 50 372
2025 September 397 65 462
2025 August 443 67 510
2025 July 493 37 530
2025 June 430 42 472
2025 May 689 55 744
2025 April 399 32 431
2025 March 368 22 390
2025 February 331 28 359
2025 January 327 20 347
2024 December 264 21 285
2024 November 304 33 337
2024 October 256 50 306
2024 September 219 26 245
2024 August 242 60 302
2024 July 252 24 276
2024 June 289 40 329
2024 May 300 59 359
2024 April 309 46 355
2024 March 363 32 395
2024 February 353 28 381
2024 January 436 29 465
2023 December 429 34 463
2023 November 500 53 553
2023 October 467 65 532
2023 September 401 41 442
2023 August 335 19 354
2023 July 343 33 376
2023 June 315 37 352
2023 May 290 49 339
2023 April 279 19 298
2023 March 260 25 285
2023 February 271 26 297
2023 January 220 33 253
2022 December 224 25 249
2022 November 248 26 274
2022 October 289 42 331
2022 September 302 47 349
2022 August 241 28 269
2022 July 209 52 261
2022 June 294 39 333
2022 May 293 32 325
2022 April 329 43 372
2022 March 369 42 411
2022 February 348 35 383
2022 January 364 26 390
2021 December 388 46 434
2021 November 330 40 370
2021 October 335 81 416
2021 September 280 40 320
2021 August 304 33 337
2021 July 305 35 340
2021 June 351 15 366
2021 May 428 34 462
2021 April 875 62 937
2021 March 605 35 640
2021 February 503 32 535
2021 January 633 36 669
2020 December 584 33 617
2020 November 451 24 475
2020 October 553 27 580
2020 September 506 31 537
2020 August 481 32 513
2020 July 413 22 435
2020 June 427 33 460
2020 May 525 44 569
2020 April 464 25 489
2020 March 428 42 470
2020 February 540 24 564
2020 January 515 36 551
2019 December 495 66 561
2019 November 445 27 472
2019 October 400 25 425
2019 September 437 36 473
2019 August 369 38 407
2019 July 479 98 577
2019 June 320 82 402
2019 May 258 64 322
2019 April 249 28 277
2019 March 281 35 316
2019 February 281 36 317
2019 January 281 23 304
2018 December 356 35 391
2018 November 280 29 309
2018 October 243 30 273
2018 September 186 29 215
2018 August 207 32 239
2018 July 101 20 121

Alcoholic cardiomyopathy (ACM) is a condition of toxic origin that causes gradual changes in the structure and function of the heart, resembling those seen in idiopathic dilated cardiomyopathy (CMP). ACM occurs in persons who consume large amounts of alcohol (>100g/d in men, > 80g/d in women) over a long period of time (at least 5 years, usually around 15 years) in the absence of other significant heart disease.1–3 In western countries, this condition accounts for approximately one third of all cases of acquired dilated CMP. ACM may affect up to one third of all consumers of large amounts of alcohol.2 As the overall alcohol consumption of the Spanish population has not decreased in recent years, neither has the incidence of ACM, and alcohol intake continues to be an important risk factor for both ACM and cardiovascular disease.3 Moreover, the harmful effects of alcohol may be added to those of other cardiovascular risk factors, such as hypertension, diabetes mellitus, and hypercholesterolemia. It has also been reported that, because of the toxic systemic effect of alcohol and its metabolites, other organic diseases related to alcohol use, such as liver cirrhosis, alcoholic dementia, and protein-calorie malnutrition, increase the risk of developing ACM.3

For many years, the potential reversibility of ACM has been a subject of medical interest. Already in the IV century BC in Greece, Hippocrates observed that patients with “hydropsy”, the clinical equivalent of congestive heart disease, improved when they stopped drinking alcohol, a recommendation that has persisted to this day. However, we need to look back to the XIX century in German beer drinkers to find clear clinical descriptions of ACM reversibility with abstinence from alcohol. In t, for a very long time people doubted that alcohol consumption, in itself, was the cause of dilated CMP. It was suggested that contaminants in the beer such as cobalt and arsenic used as defoaming agents brought about this condition, and not the ethanol. Another proposal was that ACM could be caused by the protein-calorie malnutrition, thiamine deficiency (western Beriberi), or the deficits in selenium, magnesium, or phosphorus that are often associated with chronic alcohol consumption.4

Some 30 years ago, several clinical and experimental studies verified that ethanol was the cause of this toxic dilated CMP, and that there was a clear dose-dependent effect related to the cumulative alcohol consumption over the lifetime of each person.2 This generated the concept of total lifetime alcohol intake (LAI) per kilogram of body weight as an approach to better estimate the personal risk of developing ACM. Thus, the natural history of ACM has been defined as a chronic disease that initiates with a subclinical phase in which the only change observed is left ventricular diastolic dysfunction.5 This is followed by the systolic dysfunction phase, with a gradual decrease in left ventricular ejection fraction (LVEF). In this phase, events related to congestive heart failure and arrhythmias appear, and there is a clear increase in mortality in persons who continue to consume large amounts of alcohol.6 Binge drinking is particularly detrimental over the course of ACM, as it can trigger acute cardiac events of this type (holiday heart syndrome).3 It was also seen that women are more prone to develop ACM than men7 and that some genetic polymorphisms such as angiotensin-converting enzyme DD genotype increase the risk of developing this condition.3,6

With regard to the pathogenesis of ACM, it is currently considered to be a direct toxic effect of alcohol through multifactorial and synergistic mechanisms. These include Ca2+-dependent signal transduction changes affecting myocardial contractility, the antioxidant and proinflammatory effects of alcohol and acetaldehyde, changes in the synthesis of structural and contractile proteins, and apoptosis induction, with consequent cardiomyocyte loss and replacement by subendocardial and interstitial fibrosis1,4 (Figure 1). Furthermore, alcohol inhibits cardiomyocyte repair and replication mechanisms, which worsens myocardial remodeling.3 Finally, a recent study suggested that certain myokines (FGF-21, METRNL, IGF-1, myostatin) may play a role in modulating ethanol-induced myocardial injury and myocardial repair mechanisms.8

Image Left ventricular myocardial biopsy. Patient wi...Figure 1.

Left ventricular myocardial biopsy. Patient with chronic alcoholic cardiomyopathy. There is marked cellular and nuclear hypotrophy, destructuring of the sarcomeric pattern of cardiomyocytes, and interstitial fibrosis. Electron microscopy of a semithin section × 600 magnification, stained with toluidine blue.

(0.09MB).

Based on these data, it is it is reasonable to conclude that all ACM patients should completely abstain from alcohol.2–4 However, in general, these patients have an elevated LAI (> 20kg of ethanol/kg of body weight) and are alcohol-dependent. Despite undergoing specific detoxification programs, not all patients achieve lasting alcohol abstinence. Around one third continue drinking large amounts of alcohol despite recommendations to abstain, which leads to high mortality, at an annual rate of more than 10%. Another subgroup (30%-40%) is only able to reduce previous alcohol consumption to moderate doses (Figure 2.

Alcoholic cardiomyopathy reversibility according to the patients’ consumption over time. Alcoholic cardiomyopathy patients who remain abstinent show better left ventricular ejection fraction (LVEF) recovery than the other groups. LVEF in patients who continue consuming large amounts of alcohol (> 80g/d) show a poorer clinical course. Of note, patients who did not achieve abstinence, but managed to decrease alcohol intake to < 60g/d (considered to be controlled consumption) showed an improvement similar to that of abstainers. (Reproduced with the permission of Nicolás et al.)10.

(0.29MB).

We believe that the recent article by Amor-Salamanca et al.14 in Revista Española de Cardiología, assessing the prognostic impact and related predictive factors of LVEF recovery in patients with ACM, helps to clarify this situation. The authors monitored the long-term clinical course of 101 ACM patients for a mean of 82 months. A significant LVEF increase was seen in 42% of patients (absolute increase > 10% and final LVEF > 40%), and these patients had a better prognostic course than those without LVEF recovery. The predictive factors of LVEF recoverydefined by the authors were QRS duration < 120ms, beta-blocker treatment, and no requirement for diuretics, all of which seem logical. QRS duration < 120ms has been related to higher LVEF values and longer survival in dilated CMP patients, and with fewer episodes of heart failure with decreased LVEF.15 Beta-blocker treatment is clearly related to improved LVEF and a smaller number of arrhythmias in dilated CMP. The fact of not needing diuretics is associated with better baseline left ventricular function, as the signs of cardiac congestion only appear in advanced phases of ACM.4 Curiously, alcohol consumption was not a predictive factor of LVEF improvement in this study, although the LVEF did not recover in any of the 6 patients who maintained excessive intake. This may have been because the study population did not include patients who consumed large amounts of alcohol (> 200g/d), in contrast to other studies.2,10 Furthermore, alcohol consumption was not measured in grams, but instead, in intervals, which decreased the power of this parameter in the statistical analysis. As to the ACM patients who maintained moderate alcohol intake, this study also found that the percentage with LVEF recovery was similar to that of abstainers (44% vs 45% respectively). This led the authors to conclude that there is a relationship between LVEF recovery and the prognostic course of ACM patients, and that LVEF recovery is similar between moderate drinkers and abstainers.

We should like to point out 2 aspects in the study by Amor-Salamanca et al.14 that we consider crucial to reversing ACM. The first is that abstinence is the best strategy to achieve functional recovery, but when abstinence is not attained, controlling alcohol intake is also useful. However, it is not beneficial to recommend moderate drinking in ACM patients with alcohol dependence, as they have a nonnegligible risk of relapsing to high-dose consumption. Hence, we believe that the physician's recommendation of abstinence should always prevail over that of controlled consumption.3,6 This leads us to a widely mentioned norm applicable to this situation “less alcohol is best for the heart”.3 The second aspect to mention is the following: As left ventricular dysfunction is the most important functional marker of ACM, LVEF recovery is the best parameter for monitoring ACM patients over time.

Estimating the prognostic course is important in ACM, not only in clinical terms, but also to evaluate potential treatment interventions, such as cardiac resynchronization with implantable automatic defibrillator placement or inclusion in a heart transplant program. According to the findings of the study by Amor-Salamanca et al.,14 a cutoff point of 40% for LVEF recovery could be the limit indicating a favorable prognosis, as mortality in CMP patients with LVEF > 40% is very low. Therefore, a reasonable objective for all ACM patients would be to achieve LVEF recovery to > 40%. It is known that treatment with beta-blockers and angiotensin-converting enzyme inhibitors//angiotensin II receptor agonists is useful for improving heart function.11 We also consider that, although diuretic use was found to be a negative predictive factor in this study, it identifies patients in more advanced phases of ACM and therefore, diuretic use should not be withdrawn in the congestive phase of this condition. Lastly, although sufficient evidence is still lacking to recommend their use, new strategies have been proposed to attain functional recovery in ACM patients. These include the use of cardiomyokines or myocardial growth and regulation factors, as well as various techniques for myocardial cell regeneration. These approaches will have to be considered in the future to improve the prognostic course of patients whose LVEF does not recover up to at least 40% with the usual measures.8

CONFLICTS OF INTEREST

J. Fernández-Solà is the principal investigator in Proyecto 2015 33/31 La Marató and is integrated in the program SGR 2017/Generalitat de Catalunya and in CIBEROBN, Instituto de Salud Carlos III.

.

 References[1]M.R. Piano.Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology.Chest, (2002), 121 pp. 1638-1650Medline[2]A. Urbano-Márquez, R. Estruch, F. Navarro-López, et al.The effects of alcoholism on skeletal and cardiac muscle.N Engl J Med., (1989), 320 pp. 409-415 http://dx.doi.org/10.1056/NEJM198902163200701 | Medline[3]J. Fernández-Solà.Cardiovascular risk and benefits of moderate and heavy alcohol consumption.Nature Rev Cardiol., (2015), 12 pp. 576-587[4]A.L. Klatsky.Alcohol and cardiovascular diseases: a historical overview.Ann NY Acad Sci., (2002), 957 pp. 7-15Medline[5]J. Fernández-Solà, J.M. Nicolás, F. Fatjó, et al.Diastolic impairment in alcoholics.Alcohol Clin Exp Res., (2000), 24 pp. 1830-1835Medline[6]A. Urbano-Márquez, J. Fernández-Solà.The effects of alcohol on skeletal and cardiac muscle.Muscle Nerve., (2004), 30 pp. 689-707 http://dx.doi.org/10.1002/mus.20168 | Medline[7]A. Urbano-Márquez, R. Estruch, J. Fernández-Solà, et al.The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men.JAMA., (1995), 274 pp. 149-154Medline[8]J. Fernández-Solà, A. Planavila Porta.New treatment strategies for alcohol-induced heart damage.Int J Mol Sci., (2016), 17 pp. 1651[9]R. Estruch, J. Fernández-Solá, L. Mont, et al.Reversibility of alcoholic myocardiopathy with abstinence: presentation of 2 cases.Med Clin (Barc)., (1989), 21 pp. 69-71[10]J.M. Nicolás, J. Fernández-Solà, R. Estruch, et al.The effect of controlled drinking in alcoholic cardiomyopathy.Ann Intern Med., (2002), 136 pp. 192-200Medline[11]G. Guzzo-Merello, J. Segovia, F. Domínguez, et al.Natural history and prognostic factors in alcoholic cardiomyopathy.JACC Heart Fail., (2015), 3 pp. 78-86 http://dx.doi.org/10.1016/j.jchf.2014.07.014 | Medline[12]L. Fauchier, D. Babuty, P. Poret, et al.Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy.Eur Heart J., (2000), 21 pp. 306-314 http://dx.doi.org/10.1053/euhj.1999.1761 | Medline[13]A. Gavazzi, R. De Maria, M. Parolini, M. Porcu.Alcohol abuse and dilated cardiomyopathy in men.Am J Cardiol., (2000), 85 pp. 1114-1118Medline[14]A. Salamanca, G. Guzzo-Merello, González-López, et al.Impacto pronóstico y factores predictores de la recuperación de la fracción de eyección en pacientes con miocardiopatía dilatada alcohólica.Rev Esp Cardiol., (2018), 71 pp. 612-619 http://dx.doi.org/10.1016/j.rec.2017.11.032 | Medline[15]W.T. O’Neal, M. Mazur, A.G. Bertoni, et al.Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction; The multi-study of atherosclerosis.J Am Heart Assoc., (2017), http://dx.doi.org/10.1161/JAHA.117.006023 Copyright © 2018. Sociedad Española de Cardiología https://doi.org/10.1016/j.rec.2018.01.016 View PDF Lea este artículo en español Share

Options

Options Images 2 Tools Statistics Related content
  • Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy
Other articles of interest
  • Diagnosis of Long QT Syndrome: Time to Stand Up!
  • Circulating Amyloid-Beta (1-40) Predicts Clinical Outcomes in Patients With Heart Failure
  • Pulmonary Hypertension–Back to the Future
  • Medically–managed Patients With NonST-segment Elevation Acute Coronary Syndromes: An Ill-defined Entity
  • The Role and Impact of Gut Microbiota in Cardiovascular Disease
Figure 1 Figure 1 Figure 2 Figure 2 Tools
  • Export citation to RIS format
  • Export citation to BibTeX format
  • Export citation to text format
  • Add to Mendeley
plumx Statistics Read 38174 Times the article has been read 3628 Total PDF 34546 Total HTML
Year/month Html Pdf Total
2026 March 178 31 209
2026 February 466 32 498
2026 January 606 50 656
2025 December 580 102 682
2025 November 418 81 499
2025 October 322 50 372
2025 September 397 65 462
2025 August 443 67 510
2025 July 493 37 530
2025 June 430 42 472
2025 May 689 55 744
2025 April 399 32 431
2025 March 368 22 390
2025 February 331 28 359
2025 January 327 20 347
2024 December 264 21 285
2024 November 304 33 337
2024 October 256 50 306
2024 September 219 26 245
2024 August 242 60 302
2024 July 252 24 276
2024 June 289 40 329
2024 May 300 59 359
2024 April 309 46 355
2024 March 363 32 395
2024 February 353 28 381
2024 January 436 29 465
2023 December 429 34 463
2023 November 500 53 553
2023 October 467 65 532
2023 September 401 41 442
2023 August 335 19 354
2023 July 343 33 376
2023 June 315 37 352
2023 May 290 49 339
2023 April 279 19 298
2023 March 260 25 285
2023 February 271 26 297
2023 January 220 33 253
2022 December 224 25 249
2022 November 248 26 274
2022 October 289 42 331
2022 September 302 47 349
2022 August 241 28 269
2022 July 209 52 261
2022 June 294 39 333
2022 May 293 32 325
2022 April 329 43 372
2022 March 369 42 411
2022 February 348 35 383
2022 January 364 26 390
2021 December 388 46 434
2021 November 330 40 370
2021 October 335 81 416
2021 September 280 40 320
2021 August 304 33 337
2021 July 305 35 340
2021 June 351 15 366
2021 May 428 34 462
2021 April 875 62 937
2021 March 605 35 640
2021 February 503 32 535
2021 January 633 36 669
2020 December 584 33 617
2020 November 451 24 475
2020 October 553 27 580
2020 September 506 31 537
2020 August 481 32 513
2020 July 413 22 435
2020 June 427 33 460
2020 May 525 44 569
2020 April 464 25 489
2020 March 428 42 470
2020 February 540 24 564
2020 January 515 36 551
2019 December 495 66 561
2019 November 445 27 472
2019 October 400 25 425
2019 September 437 36 473
2019 August 369 38 407
2019 July 479 98 577
2019 June 320 82 402
2019 May 258 64 322
2019 April 249 28 277
2019 March 281 35 316
2019 February 281 36 317
2019 January 281 23 304
2018 December 356 35 391
2018 November 280 29 309
2018 October 243 30 273
2018 September 186 29 215
2018 August 207 32 239
2018 July 101 20 121
Are you a healthcare professional authorized to prescribe or dispense medications? Yes No Allergology and ImmunologyAnesthesiology and ResuscitationAngiology and Vascular SurgeryPharmaceutical CareBioethicsCardiologyVeterinary CardiologyOral and Maxillofacial SurgeryCardiovascular SurgeryMaxillofacial Surgery and DentistryOrthopedic and Trauma SurgeryThoracic SurgeryNursing Auxiliary CareDermatologyEndocrinology and NutritionEndodonticsInfectious Diseases and MicrobiologyCommunity Nursing and Public HealthPediatric NursingStomatologyCommunity PharmacyHospital PharmacyPharmacology and TherapeuticsGeneral PhysiotherapyGastroenterology and HepatologyGeriatricsHistory, Humanities, and Medical LiteratureDiagnostic ImagingImmunologyEmergency MedicineSports MedicineFamily and Community MedicineGeneral MedicineIntensive Care and Emergency MedicineInternal MedicineLegal and Forensic MedicineNuclear Medicine and RadiodiagnosticsNephrologyPulmonologyNutrition and DieteticsObstetrics and GynecologyOcclusion and Temporomandibular JointOphthalmology and OptometryOncologyOptometryOtorhinolaryngology (ENT)Medical PathologyPediatricsSmall AnimalsClinical PsychologyPsychiatryChildcareRadiodiagnosisRadiopharmacyRheumatologyPublic Health and Health AdministrationPublic and Community HealthSenologyPharmaceutical TechnologyAlternative TherapiesToxicologyTraumatology and OrthopedicsEmergency Medical TechnicianEmergency CareUrology

Tag » Alcohol Ejection Fraction